Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort

scientific article published on 28 November 2019

Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41598-019-54390-W
P932PMC publication ID6883054
P698PubMed publication ID31780809

P50authorSeong-Sik ChoQ47400664
Sang-Ho JoQ89090600
Min-Ho LeeQ90438938
P2093author name stringSung Eun Kim
Hyeon-Cheol Gwon
Seung Hwan Han
Tae-Hyun Yang
Seung-Woon Rha
Jung-Won Suh
Byoung-Kwon Lee
Keun-Ho Park
Sung-Ho Her
Sang Hong Baek
Kwan Yong Lee
Won-Woo Seo
P2860cites workIn vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesisQ28166439
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effectsQ28217555
Variant angina aggravated by aspirinQ28318646
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound studyQ30450312
Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in KoreaQ38560671
The Who, What, Why, When, How and Where of Vasospastic AnginaQ38674498
Cardiac and Coronary Prostaglandin Synthesis and FunctionQ39721669
Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: A randomized controlled trialQ40122257
Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysisQ40657801
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapyQ41573080
The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.Q41721219
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyQ41968141
Clinical outcomes of low-dose aspirin administration in patients with variant angina pectorisQ46210202
Impaired endothelial vasomotor function after sirolimus-eluting stent implantation.Q50707810
New-onset atrial fibrillation during acute coronary syndromes: predictors and prognosis.Q51716874
Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients.Q53369161
Exercise-induced angina provoked by aspirin administration in patients with variant anginaQ70781929
Effect of aspirin in large doses on attacks of variant anginaQ71657413
Effect of clopidogrel on nitric oxide levels in an ischemia reperfusion modelQ80066204
Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013)Q85662433
P433issue1
P921main subjectaspirinQ18216
clopidogrelQ410237
P304page(s)17783
P577publication date2019-11-28
P1433published inScientific ReportsQ2261792
P1476titleClopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort
P478volume9

Reverse relations

Q90814324Coronary Plaque Characteristics and Cut-Off Stenosis for Developing Spasm in Patients with Vasospastic Anginacites workP2860

Search more.